Raven Biotechnologies

Raven Biotechnologies is a company focused on the discovery and development of monoclonal antibody therapeutics for oncology through its cancer stem cell program. It was acquired by Macrogenics in 2008

Jeanine Mather, Founder, CEO & CSO
Springboard Alumna, 2000